Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
daratumumab
daratumumab
Brand names: Darzalex
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 100 mg/5 mL (5 mL); 400 mg/20 mL (20 mL) |
Last updated: Jan. 9, 2024
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.